Comment
. 2007 Jun 30;31(5):1149-50; author reply 1151-2.
doi: 10.1016/j.pnpbp.2007.03.018.
Epub 2007 Apr 1.
Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder
- PMID: 17493730
- DOI: 10.1016/j.pnpbp.2007.03.018
Item in Clipboard
Comment
Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder
Prog Neuropsychopharmacol Biol Psychiatry.
.
No abstract available
Comment on
-
Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):210-6. doi: 10.1016/j.pnpbp.2006.09.002. Epub 2006 Oct 13. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17046131 Clinical Trial.
Similar articles
-
Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):210-6. doi: 10.1016/j.pnpbp.2006.09.002. Epub 2006 Oct 13. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17046131 Clinical Trial.
-
OROS methylphenidate in the treatment of adults with ADHD: a 6-month, open-label, follow-up study.Ann Clin Psychiatry. 2010 Aug;22(3):196-204. Ann Clin Psychiatry. 2010. PMID: 20680193 Clinical Trial.
-
Attention deficit hyperactivity disorder in children.Clin Evid. 2002 Jun;(7):262-71. Clin Evid. 2002. Update in: Clin Evid. 2002 Dec;(8):280-90. PMID: 12230649 Updated. Review. No abstract available.
-
Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.J Clin Psychopharmacol. 2009 Jun;29(3):239-47. doi: 10.1097/JCP.0b013e3181a390ce. J Clin Psychopharmacol. 2009. PMID: 19440077 Clinical Trial.
-
OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Expert Rev Neurother. 2009. PMID: 19673602 Review.
Cited by
-
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2. Cochrane Database Syst Rev. 2018. PMID: 29744873 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
